Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Fuji
Cantor Fitzgerald
Medtronic
Deloitte
AstraZeneca
Colorcon
Federal Trade Commission
Farmers Insurance

Generated: June 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021016

« Back to Dashboard

NDA 021016 describes RELPAX, which is a drug marketed by Pfizer Ireland and is included in one NDA. It is available from five suppliers. Additional details are available on the RELPAX profile page.

The generic ingredient in RELPAX is eletriptan hydrobromide. There are twelve drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the eletriptan hydrobromide profile page.
Summary for 021016
Tradename:RELPAX
Applicant:Pfizer Ireland
Ingredient:eletriptan hydrobromide
Patents:0
Pharmacology for NDA: 021016
Suppliers and Packaging for NDA: 021016
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RELPAX eletriptan hydrobromide TABLET;ORAL 021016 NDA Roerig 0049-2330 N 0049-2330-45
RELPAX eletriptan hydrobromide TABLET;ORAL 021016 NDA Roerig 0049-2340 N 0049-2340-05

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 20MG BASE
Approval Date:Dec 26, 2002TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 40MG BASE
Approval Date:Dec 26, 2002TE:ABRLD:Yes

Expired US Patents for NDA 021016

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Ireland RELPAX eletriptan hydrobromide TABLET;ORAL 021016-002 Dec 26, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer Ireland RELPAX eletriptan hydrobromide TABLET;ORAL 021016-001 Dec 26, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer Ireland RELPAX eletriptan hydrobromide TABLET;ORAL 021016-002 Dec 26, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer Ireland RELPAX eletriptan hydrobromide TABLET;ORAL 021016-001 Dec 26, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
US Department of Justice
Baxter
Teva
Cipla
Express Scripts
Deloitte
Cantor Fitzgerald
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.